Rhode Island 2025 Regular Session

Rhode Island House Bill H5173

Introduced

1/24/25

Refer

1/24/25

Caption

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Companion Bills

No companion bills found.

Similar Bills

FL H0597

Diabetes Management in Schools

NJ A4548

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

KY HB75

AN ACT relating to undesignated glucagon.

KY HB174

AN ACT relating to undesignated glucagon.

FL S0772

Diabetes Management in Schools

KY HB263

AN ACT relating to undesignated glucagon.

MA H671

Relative to undesignated glucagon rescue therapies in schools

TX HB350

Relating to the use of glucagon medication on certain public and private school campuses.